Sonography Guided Transcervical Ablation of Uterine Fibroids (SONATA)
Evaluation of the Gynesonics System for Transcervical Treatment of Symptomatic Uterine Fibroids With Radiofrequency Ablation Under Integrated Intrauterine Sonography Guidance
Sponsor: Gynesonics
Listed as NCT02228174, this NA trial focuses on Menorrhagia and remains completed. Sponsored by Gynesonics, it has been updated 13 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Nov 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Nov 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gynesonics
For direct contact, visit the study record on ClinicalTrials.gov .